Lack of modifying potential of 8-methoxypsoralen in the promotion or progression stages of lung carcinogenesis in A/J female mice

  • Authors:
    • Toshiya Kuno
    • Masanao Yokohira
    • Yoko Matsuda
    • Satoshi Suzuki
    • Nozomi Hashimoto
    • Keiko Yamakawa
    • Kousuke Saoo
    • Katsumi Imaida
  • View Affiliations

  • Published online on: October 1, 2008     https://doi.org/10.3892/or_00000072
  • Pages: 767-772
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Pretreatment with 8-methoxypsoralen (8-MOP), a potent human CYP2A6 inhibitor, strongly suppresses lung tumorigenesis by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in female A/J mice. Since it has been reported that CYP2A protein is highly expressed in NNK-induced lung adenomas and adenocarcinomas, potential anticancer properties of 8-MOP in female A/J mice were examined subsequent to initiation. The agent was administered at 100 ppm levels in the diet during the promotion phase (experimental weeks 1-16) and progression phase (experimental weeks 16-32) and mice were sacrificed for histopathological examination of lung tumor development at 16 and 32 weeks after the initiation of NNK treatment (2 mg/0.1 ml saline/mouse, i.p.), respectively. Chemopreventive effects of 8-MOP were not observed in either experiment. In addition, no modifying effects on hepatic mRNA levels for CYP2A5, considered to be the mouse ortholog of human CYP2A6, were evident. On immunohistochemical analysis, the CYP2A protein was found to be overexpressed in all lung adenomas and adenocarcinomas, with or without 8-MOP. It can be concluded from the present data that 8-MOP at 100 ppm in the diet does not prevent mouse lung carcinogenesis when administered in the post-initiation phase.

Related Articles

Journal Cover

October 2008
Volume 20 Issue 4

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Kuno T, Yokohira M, Matsuda Y, Suzuki S, Hashimoto N, Yamakawa K, Saoo K and Imaida K: Lack of modifying potential of 8-methoxypsoralen in the promotion or progression stages of lung carcinogenesis in A/J female mice. Oncol Rep 20: 767-772, 2008
APA
Kuno, T., Yokohira, M., Matsuda, Y., Suzuki, S., Hashimoto, N., Yamakawa, K. ... Imaida, K. (2008). Lack of modifying potential of 8-methoxypsoralen in the promotion or progression stages of lung carcinogenesis in A/J female mice. Oncology Reports, 20, 767-772. https://doi.org/10.3892/or_00000072
MLA
Kuno, T., Yokohira, M., Matsuda, Y., Suzuki, S., Hashimoto, N., Yamakawa, K., Saoo, K., Imaida, K."Lack of modifying potential of 8-methoxypsoralen in the promotion or progression stages of lung carcinogenesis in A/J female mice". Oncology Reports 20.4 (2008): 767-772.
Chicago
Kuno, T., Yokohira, M., Matsuda, Y., Suzuki, S., Hashimoto, N., Yamakawa, K., Saoo, K., Imaida, K."Lack of modifying potential of 8-methoxypsoralen in the promotion or progression stages of lung carcinogenesis in A/J female mice". Oncology Reports 20, no. 4 (2008): 767-772. https://doi.org/10.3892/or_00000072